Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SOPHiA GENETICS (SOPH) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for SOPHiA GENETICS (SOPH) over the last 6 years, with Q2 2025 value amounting to $590.0.

  • SOPHiA GENETICS's Shares Outstanding (Weighted Average) rose 3409.09% to $590.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $590.0, marking a year-over-year increase of 3409.09%. This contributed to the annual value of $1330.0 for FY2021, which is 4301.08% up from last year.
  • As of Q2 2025, SOPHiA GENETICS's Shares Outstanding (Weighted Average) stood at $590.0, which was up 3409.09% from $440.0 recorded in Q2 2024.
  • SOPHiA GENETICS's Shares Outstanding (Weighted Average)'s 5-year high stood at $1330.0 during Q4 2021, with a 5-year trough of $40.0 in Q1 2023.
  • In the last 5 years, SOPHiA GENETICS's Shares Outstanding (Weighted Average) had a median value of $615.0 in 2021 and averaged $565.0.
  • In the last 5 years, SOPHiA GENETICS's Shares Outstanding (Weighted Average) skyrocketed by 4301.08% in 2021 and then tumbled by 3333.33% in 2023.
  • SOPHiA GENETICS's Shares Outstanding (Weighted Average) (Quarter) stood at $1330.0 in 2021, then crashed by 41.35% to $780.0 in 2022, then fell by 17.95% to $640.0 in 2023, then crashed by 31.25% to $440.0 in 2024, then soared by 34.09% to $590.0 in 2025.
  • Its last three reported values are $590.0 in Q2 2025, $440.0 for Q2 2024, and $640.0 during Q2 2023.